Terms: = Lung cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Clinical Outcome
3 results:
1. Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience.
Chatzikonstantinou G; Zamboglou N; Baltas D; Ferentinos K; Bon D; Tselis N
Brachytherapy; 2019; 18(6):829-834. PubMed ID: 31500935
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer.
Rutkowski J; Cyman M; Ślebioda T; Bemben K; Rutkowska A; Gruchała M; Kmieć Z; Pliszka A; Zaucha R
Cell Immunol; 2017 Dec; 322():26-33. PubMed ID: 28939130
[TBL] [Abstract] [Full Text] [Related]
3. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
Yang Y; Ahn YH; Chen Y; Tan X; Guo L; Gibbons DL; Ungewiss C; Peng DH; Liu X; Lin SH; Thilaganathan N; Wistuba II; Rodriguez-Canales J; McLendon G; Creighton CJ; Kurie JM
J Clin Invest; 2014 Jun; 124(6):2696-708. PubMed ID: 24762440
[TBL] [Abstract] [Full Text] [Related]
